{"id":"W4405374307","doi":"10.1016/j.iotech.2024.100796","title":"168TiP A phase I dose escalation/expansion study of GSK5764227 (GSK’227), a B7-homolog 3 (B7-H3) protein targeted antibody-drug conjugate (ADC), in patients with advanced solid tumours","year":2024,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"Institut National Du Cancer; Eisai; Fondation ARC pour la Recherche sur le Cancer; Seagen; Astellas Pharma; NuCana; Sanofi; Exelixis; BeiGene; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Conjugate; Antibody-drug conjugate; Antibody; Medicine; Drug; Cancer research; Monoclonal antibody; Pharmacology; Immunology; Mathematics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004405006,0.0008325378,0.0009925081,0.0003401575,0.0002577347,0.0007099393,0.0004917659,0.0008629145,0.005243259],"category_scores_gemma":[0.0003724207,0.0003886131,0.0008744631,0.0002838352,0.0005378152,0.0005007915,0.0002345244,0.003343496,0.001605028],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005883814,"about_ca_system_score_gemma":0.0009324507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001239714,"about_ca_topic_score_gemma":0.002069412,"domain_scores_codex":[0.9998345,0.00004554596,0.000007944807,0.00002881435,0.00002261153,0.00006047172],"domain_scores_gemma":[0.9997905,0.00002887814,0.00002380764,0.00002445665,0.00001680389,0.0001154902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.348612,0.09318656,0.005824485,0.001196142,0.001247647,0.000849777,0.000487246,0.00633571,0.2347343,0.001134776,0.02099846,0.2853929],"study_design_scores_gemma":[0.3590004,0.5868213,0.01123613,0.00005230906,0.0005153039,0.0007283782,0.0001000815,0.002956323,0.02656339,0.0004035508,0.01157361,0.00004919693],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889317,0.00175812,0.0008042096,0.0007985807,0.0002180602,0.001453106,0.001363495,0.0002236397,0.004449042],"genre_scores_gemma":[0.9840443,0.00147366,0.001916665,0.0008602854,0.00009614522,0.001446259,0.003098497,0.00004797605,0.007016197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005243259,"threshold_uncertainty_score":0.01754051,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007515845738382482,"score_gpt":0.342843778635392,"score_spread":0.3353279328970095,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}